DelMar Pharmaceuticals Announces $3.6 Million Registered Direct Offering
June 03, 2019 VANCOUVER, British Columbia and MENLO PARK, Calif., June 3, 2019 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development… Read More


